samedan logo

 
 
spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Wool packaging firm’s green scheme goes ‘beyond recycling’


An award-winning company that has spent more than 10 years innovating in sustainable packaging has launched a scheme that it says goes ‘beyond recycling’ – by allowing the end user to return their packaging directly to them to be used again.

Staffordshire-based Woolcool has pioneered the use of 100% natural sheep wool to insulate Pharma products, investing millions in research and development to create ecologically-sound packaging.

Its range of boxes, pouches, envelopes and liners are used by the likes of Unilever, Henry Schein, The Dental Directory and Pharmacy2U – as well as food clients such as John Lewis and Abel & Cole - while the firm has picked up numerous accolades, including the prestigious Queens’s Award for Innovation.

Now Woolcool has launched its Circular Economy Scheme – believed to be a first for a packaging company of this kind – which will enable customers to return wool insulation to be cleaned and reused.

“Through years of investment in research and testing, we have proven time and again that not only is the pure wool we use biodegradable and compostable, it outperforms man-made insulating materials such as polystyrene,” said Managing Director Josie Morris.

“So, while polystyrene and other non-sustainable alternatives clog up landfill sites, taking centuries to break down, our natural wool products biodegrade quickly, releasing valuable minerals into the earth.

“While the processes that manufacture man-made insulators may impact on the planet, the wool we use is an abundant natural material.

“But even with its fantastic bio-degradable properties, we want each and every one of the natural wool liners to have even less ecological impact. Wool is an amazing material and so we want to make sure we are reusing this as many times of possible.

“We predominately sell Business to Business, however we take our responsibility in this chain very seriously, ensuring we are always working to reduce our impact on the environment. As the manufacturer of the packaging, we have now set up a scheme that allows our customer’s customers, to send the packaging back to us directly.”

“This sense of our responsibility has led us to launch our Circular Economy Scheme, the next step on the road to true sustainability.

“The scheme allows the ecologically-minded consumer to return their 100% wool insulated liners to us for re-use. For free.''

Under the scheme, Woolcool is utilising the 7000+ stores and collection points of the CollectPlus parcel network in the UK.

The company is encouraging regular customers to collect as many liners as they can, box them up and send them back, for the wool to be washed and prepared for reuse.

“Whilst having the ability to recycle, like turning a material into something new, such as a bin bag or plant pot, is extremely important, the real secret to sustainable packaging is not just recycling – it is re-use, reusing the material as many times as possible and reducing the amount of new material being created” Josie said.

“Woolcool is paying the costs of enabling this ground-breaking scheme, because it perfectly sums up our ecological ethos and determination to find packaging solutions that are not only good for customers, products and consumers, but they also help protect the earth.”

M/F

For more details about Woolcool’s Circular Economy Scheme, visit: https://www.woolcool.com/pioneers/

 
Print this page
Send to a friend
   
spacer
News and Press Releases

Smart Bioprocessing with the new Eppendorf Control System

Hamburg, February 12, 2020 Working with flexible systems that evolve with the changing needs in a lab is indispensable. With the SciVario twin, Eppendorf, a key life science company, introduces its latest bioreactor control system for small- and bench-scale applications. The intelligent controller and new, innovative bay-drawer system enables the exchange of standardized modules to flexibly adapt the controller to the changing requirements in a laboratory.
More info >>


White Papers

Case Study: Cmed’s Mobile Data Management Solution

Cmed Clinical Services

The trial presented to Cmed was a randomized, double blinded, placebo and active controlled study to evaluate the cardiac safety of multiple doses of [study drug] in health volunteers. The pharmaceutical company, who were into the second year of development of a potential blockbuster compound for the treatment of chronic myelogenous leukaemia (CML), were requested by the FDA to design a trial to provide information on the cardiac safety of different dose levels of the study drug in healthy adult volunteers. The primary objective of the study was specifically to find the maximum tolerated dose before QTc levels became unsafe. All development of the compound was put on hold until the results of this study were submitted to the FDA and approval granted for the compound to progress into full development.
More info >>

Industry Events

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

8-11 February 2021, Vienna, Austria

In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th PBP World will be held in Vienna from 8-11 Feb 2021. This every two year held conference has gained an ever increasing impact among the pharmaceutical scientists: With up to 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement